Pauric Bannigan, Intrepid Labs, explains where AI speeds formulation decisions, why data is the bottleneck, and how active learning trains models with far less data.
News|Articles|September 2, 2015
- Pharmaceutical Technology-09-02-2015
- Volume 39
- Issue 9
Biocontainer Assemblies Provide Repeatable Performance
Meissner’s FlexGro single-use biocontainer assemblies feature the TepoFlex polyethylene (PE) multi-layer film and are delivered presterilized for immediate use.
Meissner’s FlexGro single-use biocontainer assemblies, designed for use with rocker-style bioreactors, feature the TepoFlex polyethylene (PE) multi-layer film, are available in up to 50 L and are delivered presterilized for immediate use.
The TepoFlex film offers a clean film platform, devoid of slip agents, which provides robust and repeatable performance for cell-cultivation processes, the company reports.
FlexGro biocontainer assemblies can be customized to specific end-user requirements via various sampling and process connection options, or companies can choose from standard assembly designs.
Meissner Filtration Products
Articles in this issue
about 11 years ago
Generating Savings from Room Declassificationabout 11 years ago
Cleaning a Vial Filling Lineabout 11 years ago
Establishing Limits for Dermal Absorption of Elemental Impuritiesabout 11 years ago
A Matter of Tasteabout 11 years ago
CMOs Concerned With Cost of Single-Use Equipmentabout 11 years ago
Manufacturers Face Key Policy and Regulatory Challengesabout 11 years ago
Getting Flexible with Manufacturingabout 11 years ago
Computerized Systems Validationabout 11 years ago
Collaborating on GMP Inspectionsabout 11 years ago
Going Low TemperatureRelated to this article
Stephanie Johnson, Pfizer, explains how off-platform triggers, single-owner risk registers, and traceable prior knowledge keep protein formulation programs on track.
Stephanie Johnson, Pfizer, discusses how platform formulations moved 2 Pfizer protein programs to IND in 8 months by redistributing, not removing risk.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
Univar Solutions scientists developed a lidocaine cream built on starch, sorbitol, coconut oil, and beeswax that matched a commercial benchmark on viscosity, assay, and hydration.
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
3
Manufacturing Intelligence: How AI Poisoning Hides in Plain Sight
4
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
5